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INTRODUCTION
Although  the  uptake  of  macromolecules  by
neurons  often  figures  in theories of function in  the
nervous system  (see  reference  18),  such uptake  has
actually been demonstrated only in a few instances,
usually  under  special  circumstances.  In  general,
exogenous  tracer  proteins have  been  shown  either
to  be  stopped  by  "barriers"  between  the circula-
tion and the nervous  system  (see  references  3,  29)
or to enter nonneuronal cells of nervous tissue,  such
as  Schwann  cells  and  capsule  (satellite)  cells  (see
references  21,  34).  However,  Rosenbluth  and
Wissig  (30)  using organ-cultured  ganglia or  mas-
sive  intraperitoneal  injection,  have  demonstrated
uptake  of  ferritin  by  perikarya  of toad  ganglia.
Also, Brightman  (6,  7),  using ferritin  and peroxi-
dase,  and Becker et al.  (2),  using peroxidase,  have
reported protein  uptake  by rat and mouse  central
nervous  system  neurons  after injection  of the pro-
tein directly  into  cerebrospinal  fluid or into extra-
cellular  spaces in the brain.  In  these several studies
coated  vesicles,  multivesicular  bodies,  and  dense
bodies  were  found  to  be  the  chief intraneuronal
sites  of  exogenous  protein.  In  addition,  several
authors  (1,  21,  35) have  interpreted morphological
observations  as indicating  pinocytic vesicle  forma-
tion  at neuronal  surfaces.
The  present  report  deals  with  the  uptake  of
horseradish  peroxidase  demonstrable  in  the  peri-
karya and  axons  of the  autonomic  system  which
are  scattered  through  the  rat  adrenal  gland  (the
perikarya  are  of the  ganglion  cells;  see  references
14, 33  for additional details and references)  and in
neurons  of mouse dorsal root ganglia grown in cul-
ture.
MATERIAL  AND  METHODS
Adrenal Gland Neurons
Rats were injected,  through  a tail vein, with  1.5 cc
of  a  2%  solution  of  horseradish  peroxidase  (Sigma
Chemical  Co.,  St.  Louis,  Mo.;  Type  II)  in  normal
saline.  From  15  min to  2 hr  after injection,  fixation
was initiated by perfusion, through  the heart, of 2-3 %
glutaraldehyde  in  cacodylate  or  phosphate  buffer.
Glutaraldehyde  fixation lasted for approximately  1 hr
and  was terminated  by rinsing  in cacodylate  or phos-
phate  buffer; details  of fixation methods are described
elsewhere  (15).  For  cytochemical  studies,  frozen  sec-
tions were cut at  10A for light microscopy and at 40 A
for  electron  microscopy.  Additional  tissue  was  fixed
for  electron  microscopy  without  freezing  or  incuba-
tion.
Cultured Neurons
Mouse  dorsal  root  ganglia  were  explanted  from
fetal mice  and  grown in culture  for  a minimum  of 3
wk by methods previously  published  (8,  27). Cultures
were  exposed  for  4-19  hr  to  0.2  0.3%  peroxidase
added to their usual growth medium. They were fixed
by immersion  in 2%  glutaraldehyde  in phosphate  or
cacodylate buffer  (15).  Fixation  lasted  15-30  min for
cytochemistry,  or  up to  2 hr  for  electron  microscopy
of unincubated  preparations.  After fixation, the cover
slips  carrying cultures to be  incubated were  frozen  on
the  head  of a  freezing  microtome,  and  the neurons,
with  the collagen  on which they are grown,  were  dis-
sected  off and incubated as  free-floating preparations.
For demonstration of peroxidase activity, tissue was
incubated,  at  room  temperature,  in  the  H202  and
3-3'-diaminobenzidine medium of Graham and Karn-
ovsky  (12).  Preparations  incubated  in  substrate
(H202)-free  medium  showed  no  reaction  product.l
Tissues  that had not been exposed  to peroxidase  also
were negative  when incubated  in full medium  (or in
substrate-free  medium),  except  for  occasional  axon
endings  that  showed  some  dense  granular  deposits
associated  with packed  synaptic vesicles.
All material was  postfixed in  1% osmium  tetroxide
in phosphate or Veronal-acetate  buffer,  embedded  in
Epon,  and stained  with  lead  citrate  by  usual  proce-
dures  (15).  Photographs  were  taken  with  an  RCA
EMU-3F  microscope  at  magnifications  of 2  16,000.
RESULTS
At the earliest times studied (15 min for the adrenal
gland,  4 hr for the cultures),  peroxidase  is  demon-
strable, in both systems  (Figs.  2,  6, 8),  in the spaces
between  perikarya  and  the  capsule  cells that  sur-
Initial  efforts  to  extend  our  observations  to  mice
have  been  much  hampered  by  apparent  extensive
reaction,  in  peroxide-free  medium,  of  many  cells  in
he adrenal glands  of peroxid ase-injected animals.
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Schwann  cells that  surround  them,  and  between
gland cells  and  axon endings.  At 30-35 min,  per-
oxidase  is  seen  within  the  neurons  of the  adrenal
gland  (Fig.  3);  although  the  perikarya  are  rela-
tively  rare,  they  can  be distinguished  from  gland
cells  both  on  morphological  grounds  and  on  the
basis  of  the  distribution  of  "marker"  enzyme  ac-
tivities  such  as  acid  phosphatase  (activity  in
lysosomes  and  Golgi-associated  membrane  sys-
tems)  or  thiamine  pyrophosphatase  (Golgi  ap-
paratus).  At 4 hr,  peroxidase  is present within the
cultured  mouse neurons  (Fig. 2).  By  17-19 hr,  the
cultured  neurons  show  the distribution  of peroxi-
dase-containing  bodies  indicated  in  Fig.  1;  this  is
reminiscent  of the distribution of lysosomes  (multi-
vesicular  bodies,  dense  bodies) in  these neurons  as
visualized  by  cytochemical  incubation  for  phos-
phatase and sulfatase  activity  (14).
Within  the  neurons,  much  of  the  exogenous
protein  is  found  in  perikarya.  However,  peroxi-
dase-containing  structures  are  also  regularly  en-
countered in  axons in both systems  (Figs.  2,  8,  9);
such structures are seen in  the unmyelinated axons
and axon endings of the adrenal medulla at 35 min
and  in  the unmyelinated  axons  of the  cultures  at
4 hr.  Myelinated  axons were  not  seen  to  contain
peroxidase.
Both in vivo and  in culture,  Schwann  cells  (Fig.
6)  and capsule cells  take  up considerable amounts
of exogenous  protein.
In  the neurons and in the Schwann  and capsule
cells,  peroxidase-containing  structures  include
small  vesicles  that  appear  to  form  from  the  cell
All figures,  except Fig. 1, are electron micrographs.  With  the exception  of Fig. 5,  all thin
sections  were  stained  only with  lead citrate.  For peroxidase-incubated  preparations,  in-
cubation  times  are  indicated  in  parentheses.  The  terminology  employed  in  referring  to
regions  of  neurons  is that  of Bodian  (4).  Bar length  equals 0.25  in  all electron  micro-
graphs.
FIGURE  1  Light  micrograph  of  culture neurons  fixed after  17 hr  exposure to  peroxidase
and  incubated  (35  min)  for  peroxidase  activity.  This  is  a  whole  mount  showing  unsec-
tioned neurons.  Reaction product  is seen at the borders  (C) between perikarya and capsule
cells.  In the perikarya,  peroxidase  activity  is demonstrated  in small bodies  (arrows)  that
show some tendency  to group  near the nuclei (N).  X  1,250.
FIGURE  2  Portion  of a cultured  preparation  fixed  after 4  hr exposure  to peroxidase  and
incubated  (40 min)  for peroxidase activity.  The arrows  indicate two  bodies containing re-
action product;  probably  these  are multivesicular  bodies.  One  body  is  present  in  an  un-
myelinated axon  (A);  E indicates  the  extracellular  space that separates  this  axon from
the Schwann  cell surrounding  it. The other  body is in a Schwann cell  (S)  associated  with
another  unmyelinated  axon.  X  75,000.
FIGURE  3  Portion  of a perikaryon from  an adrenal  gland  fixed 35 min  after peroxidase
injection  and  incubated  (38 min)  for peroxidase  activity.  Reaction  product  in  the extra-
cellular  space  is  seen  at  E. Activity  in  the perikaryon  is demonstrated  in  several  large
bodies  (arrows)  and in a  small vesicle  (V).  The structure at I is probably  a deep  infolding
of the cell  surface.  M indicates mitochondria.  X  20,000.
FIGURE  4  Portion  of a  perikaryon from the same peroxidase-incubated  culture used  for
Fig.  1. Reaction  product  is  present  in  a cuplike body  (arrow)  near the Golgi  apparatus.
X  65,000.
FIGURE 5  Portion of a perikaryon from a culture that had not been exposed to peroxidase.
The arrow indicates a cuplike body similar to the one seen containing peroxidase  in Fig. 4.
Similar  bodies  in  other  tissues  (15,  16)  have  been  tentatively  identified  as precursors  of
multivesicular  bodies  with  internal  vesicles presumably  derived  in  part from the infolded
membrane  of the cup. Perhaps one  such vesicle  is in the process of formation  in the body
shown in this figure. M indicates a mitochondrion,  and E identifies  endoplasmic reticulum.
The thin section was stained  with uranyl acetate and lead citrate.  X 58,000.
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(38  min)  for peroxidase  activity.
FIGURE  6  Most  of the  field  is  occupied  by  a  Schwann  cell  containing  peroxidase  reaction  product  in
large bodies  (arrows),  tubules  (T),  and a vesicle  (V).  A  indicates unmyelinated axons  associated with this
Schwann  cell.  G, the  Schwann cell  Golgi  apparatus;  M, mitochondria.  X  36,000.
FIGURE 7  Unincubated preparation  from an adrenal gland that had not been exposed to peroxidase.  The
arrow indicates an invagination of the plasma membrane of an unmyelinated  axon; a faint coating  is seen
at  its surface.  Mitochondria  are  present at M,  and small  vesicles  of the  type that  accumulate  in  large
numbers  at the  endings  of axons  are seen at V.  S indicates  a portion  of the  Schwann  cell that surrounds
this  axon.  X  67,000.
FIGURE  8  Portion  of an axon showing peroxidase  reaction product  in an  invagination of  the membrane
(arrow)  similar to  the invagination  of membrane  seen in  Fig. 7.  Reaction  product is  also present  in the
space  (E) between  axon and  Schwann  cell  (S),  including  the mesaxon  space seen  at MA.  T  indicates  a
segment  of a  ricrotubule,  and MI indicates a mitochondrion  in the axon. X  5,000.  Inserts a and b show
other  stages in the formation of vesicles  from the membranes  of two other axons  in the same preparation
as  Fig.  8. The coated  invagination at the arrow  in a is probably an early stage, while  the coated structure
at the arrow  in b presumably is  about to pinch  off as a free vesicle;  b is from an axon near  its  ending,  so
E in this case  indicates the axon-gland cell space.  a, X 69,000;  b,  X 61,000.
FIGURE  9  Portion  of  an  unmyelinated  axon.  At  the  arrow,  a peroxidase-containing  coated  vesicle  is
seen in the axoplasm.  Microtubules  are indicated by  T. Part of the  Schwann cell that surrounds the axon
is seen at S.  X  67,000.surface  (Figs.  3,  6-9).  Neuronal  vesicle  formation
is  not  confined  to  perikaryal  surfaces  and  axon
endings but is also observed  along the  axons (Figs.
(6  9).  Exogenous  protein  is  also  demonstrable
intracellularly  in  tubules  (Fig.  6)  and  in  larger
bodies  (Figs.  1  6),  including  some  bodies  resem-
bling  multivesicular  bodies  and  other bodies  like
the  cuplike bodies  (Figs. 4,  5)  that  have been seen
to  accumulate  peroxidase  in  other  tissues  (15).
None  of these  structures  is  unique  to  peroxidase-
treated  neurons;  all  of  these  structures  are  seen
(without  peroxidase  activity)  in material  that has
not been exposed  to the protein (Figs.  5,  7).
DISCUSSION
Both in  the cultures  and in  the adrenal  gland the
results  indicate  that  exogenous  protein  can
penetrate  into  the  spaces  between  neurons  and
associated  cells  and  can,  by  pinocytosis,  enter
perikarya  and axons.  Of particular  interest  is the
observation  of  uptake  of peroxidase  by  unmyeli-
nated  axons.  To our knowledge,  the only  previous
demonstration  that  exogenous  protein  can  enter
axons  is  that  of Brightman,  who  has  noted  some
ferritin  and  peroxidase  in occasional  naked  axons
in the central nervous system after protein injection
into cerebrospinal  fluid  (6,  7).  The axons  used for
the  present  study,  like  most  axons  outside  the
central  neuropil,  are  covered  by closely  associated
nonneuronal  cells  (in  the  cultures  and  adrenal
gland,  the  axons  are  covered  by  Schwann  cells).
Much  of the  peroxidase  that enters  the axons  al-
most  certainly  is  taken  up  directly  from  the
Schwann  cell-axon  space rather  than being trans-
ported  from the  perikaryon.  This  is indicated both
by observations  suggesting vesicle formation by the
axon  membrane  and  by  the fact  that  exogenous
protein  is present  in  the adrenal  gland  axons and
presynaptic  axon endings  by 35 min, which seems
too fast to be  accounted for  by known rates of flow
from  perikaryon  to  axon  (see  reference  22  for
review).
Morphological  indications  of  pinocytosis  are
observed  whether  or  not  peroxidase  is  present  in
the animal or culture.  Thus it  is unlikely  that  the
protein  is  inducing  an  abnormal  response  by  the
neurons. The  axons, endings,  and perikarya  in the
adrenal gland take up protein almost  as rapidly as
do  the  secretory  cells  (15)  of  the  cortex  and
medulla. This  suggests that the Schwann and cap-
sule  cells  are  not  particularly  effective  as
"mechanical"  barriers  and that once  material  has
left  the blood  stream it has relatively ready  access
to  the  neuronal  surface.  This contrasts,  for exam-
ple,  with the  situation  in  the central  nervous  sys-
tem (see  references 3,  6,  7).  Nevertheless,  the fact
that  Schwann  and capsule  cells do  take up  much
protein  (see  Fig.  6)  indicates that these  cells prob-
ably can restrict the amounts of exogenous macro-
molecules  that  enter  the  neurons.  Recently  (15a)
we  have  observed  apparent  peroxidase  uptake  in
Schwann  cells  of giant  crustacean  neurons;  such
Schwann  cells  also  possess  elaborate  systems  of
anastomosing  tubules  which  permit  passage  of
peroxidase  to the axon  surface through  a network
that  provides  a  large  surface  area  for  possible  ex-
changes  between  Schwann  cell  and  extracellular
medium  (15a).
Study of neuronal  protein uptake  has depended
chiefly  on  use  of culture  techniques  (30)  or direct
injection  (2,  6,  7)  to  circumvent  the  circulation,
although  Rosenbluth  and  Wissig  (30)  observed
some  ferritin  uptake  by perikarya  of toad  ganglia
17  hr  after  intraperitoneal  injection  of  0.8  g  of
protein,  and Brightman  (6,  7) has  suggested  that
limited  amounts  of blood-borne  peroxidase  might
pass the choroid  plexus by transport in vesicles.
In the present study, intravenously administered
protein  readily  gained  access  to  adrenal  gland
neurons.  However,  the  permeability of blood  ves-
sels  is  known  to  alter  in  peroxidase-injected  ani-
mals  because  of  histamine-mediated  effects  (19,
20),  and  changes  in  blood  vessel  permeability  to
protein  have  been  observed  in  response  to  a
number  of other  conditions  (see  reference  25  for
pathological  changes).  Thus  it  is  too  early  to
evaluate  the  normalcy  of  the  release  of  protein
from adrenal blood vessels. It may eventually  be of
interest  that,  in studies  of other rat nervous tissue,
intravenously  administered  peroxidase  has  not
been  detected;  this is true of central nervous  tissue
(3,  32),  neurons  of  the  nodosal  ganglion  (Holtz-
man,  E., unpublished  data),  and peripheral  nerve
(Straus, reference  32,  attributed the small amounts
of peroxidase  he found  in peripheral  nerve  to pro-
tein still in the circulation).
The  significance  of macromolecule  uptake  by
neurons  is open  to  speculation.  Passage  of intact
nucleic  acids  into  neurons  has  been  postulated  as
important for neuronal  functions  or for the  inter-
relations  of neurons  and glia  (18).  As have  others,
Pomerat,  by  microcinematographic  methods,  has
observed  morphological  signs  of intensive  pinocy-
tosis at the tips of growing  axons (28).  Neurons are
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logically  active  components  (see  reference  10)  at
rapid rates.  Rosenbluth and Wissig  (30)  have sug-
gested  that  pinocytosis  may  be  a  mechanism
whereby  the  neuron  "samples"  its  environment.
Also,  Brandt  and  Freeman  (5)  have  reported  an
interesting association  between  changes  in  electri-
cal behavior of cell membranes and increased rates
of  pinocytosis.  In  several  pathological  conditions
(see  reference  25  for further  references),  increases
in protein release from the blood stream into nerves
have been reported.
It  is  clearly  not  yet  possible  to  evaluate  ade-
quately  the  involvement  of  the  routes  of protein
uptake,  demonstrated  in the present  study, in  any
of these phenomena or to decide on the importance
of the uptake for nerve  function.  As in many other
tissues  (see  references  2,  9,  11,  12,  15,  23,  26,  30),
most of the exogenous  protein  is seen  in structures
that appear to  be lysosomes  (14,  24)  or in vesicles
and  other  bodies  that  probably  contribute  ma-
terial  to  lysosomes.  If  this  is  so,  then  lysosomal
hydrolysis  presumably  would  limit the  possibility
of direct effects of exogenous  material on neuronal
metabolism.
Recent  studies  have  shown  that  the  flow  of
macromolecules  within  neurons  involves  several
components which operate  at different rates and in
both directions  along the axon (see  reference 22 for
discussion).  Other work suggests, for example,  that
axons  can  accumulate  catecholamines  directly
from  extracellular  spaces  (10)  and  that  labeled
amino  acids  can  enter  axons  after  passing  across
Schwann  cell  cytoplasm  and  myelin  (31).  From
the present study and  from other  work  referred  to
above,  it  seems  likely  that  pinocytosis  may  be
responsible  for  part  of the  complexity  of  the  ob-
served  patterns  of  flow  and  accumulation  within
neurons  and  patterns  of  the  exchanges  between
neurons  and  the  extracellular  environment.  At
least,  direct  pinocytic  uptake  represents  an  im-
portant  potential  route  for  entry  of macromole-
cules into  all portions  of neurons, which  is  usually
overlooked  but may  turn out  to  have  appreciable
physiological  or experimental  significance
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